ArticleBiomarker research2022

KSR2-14-3-3ζ complex serves as a biomarker and potential therapeutic target in sorafenib-resistant hepatocellular carcinoma.

Chao Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.